Indian pharma company recalls blood pressure, heart drugs in the US

Blood pressure meds recalled over contamination concern

Voluntary recall issued for blood-pressure drugs over substance linked to cancer

In the recent months several companies have recalled select lots of blood pressure medication after tests revealed that they were contaminated with a small amount of a high-risk chemical that may cause cancer.

This week Aurobindo Pharma USA announced a voluntary recall of 78 lots of valsartan tablets, and Torrent Pharmaceuticals expanded its voluntary recall of losartan potassium tablets to a total of 10 lots.

The FDA is advising patients prescribed these medications to continue to take them, as the health risks may be higher if the treatment is stopped immediately without any alternative treatment.

If a person immediately stops taking the medication without finding out a suitable alternative, he/she might come across a life and death scenario.

Consumers with medical questions about the recalled medication can contact Torrent at 1-800-912-9561 from 8 a.m.to 5 p.m. EST.

MLB Free Agent Rumors: David Robertson Signs 2-Year Contract With Phillies
He was the primary closer for the White Sox for two and a half seasons and also served in that role for the Yankees in 2014. According to MLB.com's Mark Feinsand , Robertson has already passed his physical and the deal has been finalized.

'At present there is no evidence that medicines containing NDMA or NDEA have caused any harm to patients.

To date, Torrent Pharmaceuticals Limited has not received any reports of adverse events related to this recall. The drug is sold by several manufacturers, and in July of 2018 nearly a half-dozen companies were forced to recall their products due to the discovery of human carcinogens in the tablets. Do check the product name, the manufacturer details, and the batch or lot number printed on the bottle.

Anyone with concerns should consult a pharmacist, the FDA said, or call Aurobindo Pharma at 1-866-850-2876 and select Option 2. The recalled medication was distributed nationwide to distributors, repackagers, and retail customers. Aurobindo Pharma USA, Inc.is arranging for return of all recalled products to Inmar/CLS Medturn.

According to the FDA, NDEA is a chemical that can be found in drinking water and some foods, and studies have classified it as a "possible human carcinogen".

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Latest News